| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +66.67% | -7.41% | +0.48% | -7.89% | -4.20% | — |
| 14d | 6 | +66.67% | -16.43% | -0.18% | -16.25% | -18.56% | — |
| 30d | 6 | +66.67% | -14.79% | +1.89% | -16.67% | -19.68% | — |
| 60d | 6 | +66.67% | -19.38% | +0.13% | -19.51% | -24.57% | — |
| 90d | 6 | +66.67% | -28.68% | -0.65% | -28.03% | -32.50% | — |
| 180d | 6 | +50.00% | -48.51% | -1.13% | -47.39% | -50.11% | — |
| 1y | 6(1 pending) | +60.00% | -48.78% | -2.74% | -46.05% | -33.77% | — |
| 2y | 6(1 pending) | +60.00% | -72.89% | +14.54% | -87.43% | -69.45% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| MXCT MAXCYTE, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 475,000 | Mar 27, 2026 | Mar 31, 2026 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASEGRANT Stock grant | 600,000 | — | — | 600,000 | Mar 27, 2026 | Mar 31, 2026 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASE President and CEO | 75,000 | $1.37 | $102.9K | 175,000 | Aug 13, 2025 | Aug 13, 2025 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASEGRANT Stock grant | 347,500 | — | — | 347,500 | Mar 14, 2025 | Mar 18, 2025 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASE President and CEO | 70,443 | $4.90 | $345.2K | 100,000 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASE President and CEO | 29,557 | $4.87 | $143.8K | 29,557 | Jun 7, 2024 | Jun 10, 2024 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASEGRANT Stock grant | 400,000 | — | — | 400,000 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Mar 20, 2023 | Mar 21, 2023 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASEGRANT Stock grant | 242,000 | — | — | 242,000 | Mar 25, 2022 | Mar 29, 2022 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASE EVP and General Counsel | 18,562 | $3.25 | $60.3K | 18,562 | Nov 16, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | SALE EVP and General Counsel | 18,562 | $12.08 | $224.2K | 0 | Nov 16, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | SALE EVP and General Counsel | 18,562 | — | — | 0 | Nov 16, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | SALE EVP and General Counsel | 24,278 | — | — | 75,000 | Nov 15, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | SALE EVP and General Counsel | 30,716 | $12.16 | $373.5K | 0 | Nov 15, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASE EVP and General Counsel | 6,438 | $3.25 | $20.9K | 30,716 | Nov 15, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASE EVP and General Counsel | 24,278 | $2.08 | $50.5K | 24,278 | Nov 15, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | SALE EVP and General Counsel | 6,438 | — | — | 18,562 | Nov 15, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | SALE EVP and General Counsel | 25,722 | — | — | 99,278 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASE EVP and General Counsel | 25,722 | $2.08 | $53.5K | 25,722 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | SALE EVP and General Counsel | 25,722 | $12.66 | $325.6K | 0 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| MXCT MAXCYTE, INC. | PURCHASEGRANT Stock grant | 10,000 | — | — | 10,000 | Aug 9, 2021 | Aug 11, 2021 ↗ | View → |